Lmr Partners LLP Cytom X Therapeutics, Inc. Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.21 - $5.13 $3,872 - $16,416	-3,200 Reduced 17.54%	15,046 $18,000
Q1 2024 May 15, 2024	BUY	$1.41 - $2.74 $25,726 - $49,994	18,246 New	18,246 $39,000
Q2 2022 Aug 15, 2022	BUY	$1.53 - $2.89 $35,395 - $66,857	23,134 New	23,134 $42,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.